株式会社タイミー Logo

株式会社タイミー

On-demand staffing platform connecting businesses and workers for flexible spot work.

215A | T

Overview

Corporate Details

ISIN(s):
JP3449040009
LEI:
Country:
Japan
Address:
東京都港区東新橋1丁目5ー2 汐留シティセンター35階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Timee, Inc. operates "Timee," a leading on-demand staffing platform that connects individuals seeking flexible, short-term work with businesses facing immediate labor needs. The service functions as a "spot work" marketplace, allowing users to find and work jobs without the need for traditional applications or interviews, often with the benefit of same-day payment. For businesses, Timee offers a swift solution to labor shortages and fluctuating staffing demands, particularly in sectors like hospitality, logistics, and retail. The company's mission is to create a new infrastructure for work that expands individual potential and helps solve broader societal challenges related to employment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-12 08:30
Interim Report
確認書
Japanese 8.7 KB
2025-06-12 08:30
Interim Report
半期報告書-第9期(2024/11/01-2025/10/31)
Japanese 213.1 KB
2025-01-29 07:31
Post-Annual General Meeting Information
臨時報告書
Japanese 21.1 KB
2025-01-29 07:31
Registration Form
確認書
Japanese 8.7 KB
2025-01-29 07:30
Registration Form
有価証券報告書-第8期(2023/11/01-2024/10/31)
Japanese 2.5 MB
2025-01-29 07:30
Governance Information
内部統制報告書-第8期(2023/11/01-2024/10/31)
Japanese 22.5 KB
2024-07-18 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-18 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 34.2 KB
2024-07-16 08:00
Registration Form
臨時報告書
Japanese 28.6 KB
2024-07-16 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-07-09 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.9 MB
2024-07-09 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 33.4 KB
2024-07-03 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 1.8 MB
2024-06-21 08:00
Share Issue/Capital Change
臨時報告書
Japanese 29.5 KB
2024-06-21 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 3.6 MB

Automate Your Workflow. Get a real-time feed of all 株式会社タイミー filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社タイミー

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社タイミー via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

OSCOTECInc. Logo
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
South Korea
039200
OSE Immunotherapeutics Logo
Develops first-in-class immune therapies for oncology and inflammation, partnering for late-stage.
France
OSE
Oxurion NV Logo
Acquires European pharmaceutical subcontractors to build an integrated healthcare services group.
Belgium
OXUR
PA Co., Ltd Logo
Offers HR solutions like recruitment media, staffing, and childcare to revitalize local communities.
Japan
4766
Passage BIO, Inc. Logo
Developing genetic medicines for severe CNS and neurodegenerative disorders.
United States of America
PASG
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway
PCIB
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye
PCILT
PDS Biotechnology Corp Logo
Developing T-cell activating immunotherapies for cancer and infectious diseases.
United States of America
PDSB
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan
7066
PepGen Inc. Logo
Biotech using an EDO platform to treat genetic neuromuscular & neurological diseases.
United States of America
PEPG

Talk to a Data Expert

Have a question? We'll get back to you promptly.